Back to Agendas
PRAC: HIGHLIGHTS, CHALLENGES AND REFERRALS
Session Chair(s)
Sarah Montagne
Head UK/IE Regulatory Affairs
Bayer plc, United Kingdom
Sabine Straus, MD, PhD, MSc
PRAC Chair, Staff Member
Medicines Evaluation Board (MEB), Netherlands
The Impact of Imposed PASS and the Challenges of Making Multi-MAH Studies Work
Learning Objective : You will be able to recognise the impact and difficulties of organising Post Authorisation Safety Studies (PASSes) for the pharmaceutical industry when multiple Marketing Authorisation Holders are involved. This session will describe how work sharing is carried out currently and how it can be improved.
Speaker(s)
Panel Discusion
Jean-Michel Dogne
University of Namur, Agence Fédérale Des Médicaments Et Des Produits De Santé, Belgium
PRAC: Highlights from a busy agenda
Georgy Genov, MD
European Medicines Agency, Netherlands
Head of PHV Office, ad-interim Head of Quality & Safety of Medicines Department
The Impact of Imposed PASS and the Challenges of Making Multi-MAH Studies Work
Katarina Nedog, MSc
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Associate Director
Union Safety Referrals: Shared experiences of the referral journey for well-established products and the importance of effective communication
Emmanuelle Pines, MD
Pierre Fabre, France
Directeur Vigilances Monde/ Head of Corporate Vigilances Division 45
Have an account?